The role of JAKs in the pathophysiology of diseases was first demonstrated in 1995 with the identification of a loss-of-function mutation in JAK3 in severe combined immunodeficiency (SCID) [10, 11]. Here, JAK3 is linked to severe combined immunodeficiency.